Rilpivirine

Overview

A novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine seems to be well tolerated with less CNS disturbance than Efavirenz, and has non-teratogenic potential. An anti-HIV agent.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Infection | HIV

Product Information

• Catalog No.: B0084-263854
• CAS No.: 500287-72-9
• Molecular Formula: C22H18N6
• Molecular Weight: 366.428
• Purity: 98%
• Storage: Powder : -20°C: 3 years; 4°C: 2 years; In solvent: -80°C: 6 months; -20°C: 1 month
• Solubility: In vitro : 10 mM in DMSO

Source

Original product source